INDRAMEDCO

Indraprastha Medical Corporation Share Price

 

 

Invest in Indraprastha Medical Corporation with 2.04X leverage

Invest with MTF

Performance

  • Low
  • ₹470
  • High
  • ₹495
  • 52 Week Low
  • ₹307
  • 52 Week High
  • ₹641
  • Open Price₹493
  • Previous Close₹492
  • Volume212,722

Investment Returns

  • Over 1 Month -21.65%
  • Over 3 Month -1.81%
  • Over 6 Month + 8.68%
  • Over 1 Year -3.96%

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Invest Now

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.8
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 4,340
  • P/B Ratio
  • Average True Range
  • 18.86
  • EPS
  • 19.06
  • Dividend Yield
  • 1
  • MACD Signal
  • -10.66
  • RSI
  • 29.75
  • MFI
  • 27.71

Indraprastha Medical Corporation Financials

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹473.40
-18.9 (-3.84%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹517.24
  • 50 Day
  • ₹522.16
  • 100 Day
  • ₹504.33
  • 200 Day
  • ₹471.83

Resistance and Support

479.4 Pivot Speed
  • R3 513.15
  • R2 503.90
  • R1 488.65
  • S1 464.15
  • S2 454.90
  • S3 439.65

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Ltd. operates the prestigious Indraprastha Apollo Hospitals in New Delhi, providing world-class healthcare services. It offers a wide range of medical specialties, advanced diagnostics, and state-of-the-art facilities for patients from India and abroad.

Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,404.77 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 16% is great, ROE of 26% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 8% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-01 Quarterly Results
2025-08-06 Quarterly Results
2025-05-16 Audited Results & Final Dividend
2025-02-03 Quarterly Results
2024-10-30 Quarterly Results
Date Purpose Remarks
2025-09-18 FINAL Rs.4.50 per share(45%)Final Dividend
View Indraprastha Medical Corporation Dividend History Arrow

Indraprastha Medical Corporation F&O

Indraprastha Medical Corporation Shareholding Pattern

51%
2.62%
2.41%
0%
30.08%
13.89%

About Indraprastha Medical Corporation

  • NSE Symbol
  • INDRAMEDCO
  • BSE Symbol
  • 532150
  • Managing Director
  • Mr. Shivakumar Pattabhiraman
  • ISIN
  • INE681B01017

Similar Stocks to Indraprastha Medical Corporation

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹473 As on 06 December, 2025 | 23:34

The Market Cap of Indraprastha Medical Corporation is ₹4339.8 Cr As on 06 December, 2025 | 23:34

The P/E ratio of Indraprastha Medical Corporation is 24.8 As on 06 December, 2025 | 23:34

The PB ratio of Indraprastha Medical Corporation is 7.3 As on 06 December, 2025 | 23:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23